Neurocrine Biosciences



Ebitda változás Dátum
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
Dynavax Technologies USD 439K 11.7M 2024-12
Exelixis USD 171.1M 24.2M 2025-01
Gilead Sciences USD 3.21B 651M 2024-12
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
Incyte USD 320.2M 128.19M 2024-12
Intra Cellular Therapies USD -29088000 9.62M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Prothena USD -64676000 1.61M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Repligen USD 4.9M 22.12M 2024-09
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Teva Pharmaceutical Industries USD 261M 1.01B 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Neurocrine Biosciences - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.